Published in J Virol on February 01, 1991
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05
Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol (1994) 1.34
Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A (1992) 1.27
The Epstein-Barr virus and its association with human cancers. Mol Pathol (1999) 1.26
Adenovirus infection in pediatric liver transplant recipients. J Infect Dis (1992) 1.18
Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol (1994) 1.13
Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol (1996) 1.13
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06
The role of EBV in post-transplant malignancies: a review. J Clin Pathol (2000) 1.02
Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation (1994) 0.97
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol (1998) 0.85
Infectious mononucleosis hepatitis in young adults: two case reports. Korean J Intern Med (2009) 0.84
Interleukin-6 production in posttransplant lymphoproliferative disease. J Clin Invest (1993) 0.84
The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study. Transplantation (2015) 0.80
Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis (2002) 0.80
Two cases of post transplant lymphoproliferative disorder in lung transplant recipients. Korean J Intern Med (2004) 0.78
Pediatric kidney transplantation: a historical review. Pediatr Res (2016) 0.75
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A (1990) 3.29
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A (1988) 2.12
Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer (1989) 1.97
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med (1977) 1.59
Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis (1985) 1.43
Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood (1988) 1.39
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis (1987) 1.03
Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. J Virol (1988) 1.02
Lymphotropic papovavirus early region is specifically regulated transgenic mice and efficiently induces neoplasia. J Virol (1989) 1.02
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes. Proc Natl Acad Sci U S A (1985) 3.75
A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73
Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Regulation of herpes simplex virus 1 genes: alpha gene sequence requirements for transient induction of indicator genes regulated by beta or late (gamma 2) promoters. Virology (1986) 2.56
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Role of herpes simplex virus type 1 UL46 and UL47 in alpha TIF-mediated transcriptional induction: characterization of three viral deletion mutants. J Virol (1991) 2.17
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04
Viral infections in renal transplant recipients. Infect Immun (1976) 2.03
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. J Virol (1993) 1.99
The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med (1997) 1.98
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.91
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology (1988) 1.87
Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods (1995) 1.76
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis (2000) 1.71
The role of herpesviruses in adenovirus-associated virus replication in vitro. Virology (1970) 1.70
Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70
No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67
Reactivation of murine cytomegalovirus by cyclophosphamide. Nature (1977) 1.67
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
Politicizing health care. Soc Policy (1979) 1.64
Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61
Interferon. Annu Rev Microbiol (1975) 1.61
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alpha-trans-inducing factor-dependent activation of alpha genes. J Virol (1987) 1.57
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem (1997) 1.53
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49
Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr (1989) 1.47
Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 1.46
Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol (2001) 1.46
McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45
Hepatitis C virus. Another agent transmitted by transplanted organs. N Engl J Med (1991) 1.45
Cellular origin of interferon induced by bacterial lipopolysaccharide. Infect Immun (1977) 1.44
Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43
Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. J Invasive Cardiol (2000) 1.42
Studies on the relationship between adeno-associated virus type I (AAV-1) and adenoviruses. I. Replication of AAV-1 in certain cell cultures and its effect on helper adenovirus. Virology (1967) 1.41
Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg (1983) 1.41
Accentuation of production of human interferon by metabolic inhibitors. Proc Soc Exp Biol Med (1972) 1.41
Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med (1987) 1.40
Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science (1975) 1.40
Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol (1997) 1.39
Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor. Proc Soc Exp Biol Med (1965) 1.38
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38
A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis (1978) 1.37
Electron microscopy of adenovirus-associated virus (AAV) in cell cultures. Virology (1966) 1.35
Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus. J Infect Dis (1982) 1.34
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34
Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis (1978) 1.32
The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med (1987) 1.32
Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother (2001) 1.31
Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis (1984) 1.29
A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J Infect Dis (1983) 1.28
Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. J Infect Dis (1976) 1.28
Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study. Cancer (1981) 1.27
An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis. Am J Trop Med Hyg (1983) 1.26
Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans R Soc Trop Med Hyg (1985) 1.26
The mechanism of stimution of interferon production by a complexed polyribonucleotide. Virology (1970) 1.25
Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression. J Infect Dis (1978) 1.24
Fungal Infections After Liver Transplantation. Transplant Proc (1988) 1.24
Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis (1987) 1.24
Letter: Bacillus cereus endocarditis in an addict. Ann Intern Med (1974) 1.24
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis (1997) 1.23
Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol (1991) 1.23
Changes in HIV rates and sexual behavior among homosexual men, 1984 to 1988/92. Am J Public Health (1993) 1.22
Two variants of Sindbis virus which differ in interferon induction and serum clearance. I. The phenomenon. J Infect Dis (1969) 1.22